About this trial
A single-center, open-label, investigational pilot trial to explore potential effects of transcutaneous spinal cord stimulation on leg muscle strength and walking in children with myelomeningocele.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed myelomeningocele confirmed by a neurosurgeon or neurologist
Some difficulty ambulating, but able to ambulate at least a short distance (10 meters) with devices and/or assistance.
Between the ages of 4 and 17 years of age.
Documented neurogenic bladder dysfunction
Disqualifiers
Severe behavioral or cognitive impairments that preclude participation in the study, in the opinion of the investigator.
Has an active surgery planned for impairments from spina bifida (e.g. tethered cord syndrome surgery or orthopedic surgery) or has had surgery in the last 6 months.
Is pregnant. Pregnancy will be assessed via verbal report.
Open wounds at the thoracic or lumbar spine that precludes transcutaneous stimulation.
Trial design
Single group
Treatments tested in this trial
Transcutaneous stimulator
Devicean off the shelf TENS unit or Digitimer DS8R (using same parameters as TENS unit)
Treatment groups
Trial outcomes
Primary outcomes
Muscle Strength
change in isometric torque of quadriceps during knee extension
Gait Kinematics
Change in joint angles in tSCS vs no stim conditions
Bladder capacity
Change in cystometric bladder capacity with tSCS vs no stim conditions
Gait Kinetics
Changes in ground reaction forces with and without stimulation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Bailey Petersen
Lead sponsor
University of Pittsburgh
Sponsor institution